Chemocentryx Z Score

CCXI -  USA Stock  

USD 15.32  0.21  1.39%

Altman Z Score is one of the simplest fundamental models to determine how likely your company is to fail. The module uses available fundamental data of a given equity to approximate the Altman Z score. Altman Z Score is determined by evaluating five fundamental price points available from the company's current public disclosure documents. Continue to Chemocentryx Piotroski F Score and Chemocentryx Valuation analysis.

Search Z Score 

 
Refresh
Chemocentryx Market Capitalization is most likely to increase significantly in the upcoming years. The last year's value of Market Capitalization was reported at 4.29 Billion. The current Working Capital is estimated to increase to about 420.8 M, while Capital Expenditure is projected to decrease to (15.8 M). Chemocentryx Interest Expense is most likely to increase significantly in the upcoming years. The last year's value of Interest Expense was reported at 2.64 Million. The current Selling General and Administrative Expense is estimated to increase to about 45.5 M, while Consolidated Income is projected to decrease to (56.8 M).

Chemocentryx Z Score Analysis

Chemocentryx's Z-Score is a simple linear, multi-factor model that measures the financial health and economic stability of a company. The score is used to predict the probability of a firm going into bankruptcy within next 24 months or two fiscal years from the day stated on the accounting statements used to calculate it. The model uses five fundamental business ratios that are weighted according to algorithm of Professor Edward Altman who developed it in the late 1960s at New York University..
 2018 2019 2020 2021 (projected)
Interest Expense1.22 M2.15 M2.64 M2.85 M
Gross Profit42.88 M36.13 M64.89 M54.5 M
Z Score 
 = 
Sum Of  
 
5 Factors 
More About Z Score | All Equity Analysis

Current Chemocentryx Z Score

    
  1.4  
Most of Chemocentryx's fundamental indicators, such as Z Score, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Chemocentryx is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
First Factor
 = 
1.2 * (
Working Capital
/
Total Assets )
Second Factor
 = 
1.4 * (
Retained Earnings
/
Total Assets )
Thrid Factor
 = 
3.3 * (
EBITAD
/
Total Assets )
Fouth Factor
 = 
0.6 * (
Market Value of Equity
/
Total Liabilities )
Fifth Factor
 = 
0.99 * (
Revenue
/
Total Assets )

Chemocentryx Z Score Driver Correlations

Understanding the fundamental principles of building solid financial models for Chemocentryx is extremely important. It helps to project a fair market value of Ford stock properly, considering its historical fundamentals such as Z Score. Since Chemocentryx's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Chemocentryx's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Chemocentryx's interrelated accounts and indicators.
To calculate Z-Score one would need to know current working capital of the company, its total assets, and liabilities, amount of latest retained earnings as well as earnings before interest and tax. Z-Score can be used to compare the odds of bankruptcy of companies in a similar line of business or firms operating in the same industry. Companies with Z-Scores above 3.1 are generally considered to be stable and healthy with a low probability of bankruptcy. Scores that fall between 1.8 and 3.1 lie in a so-called 'grey area' with scores of less than 1, indicating the high probability of distress. Z Score is used widely by financial auditors, accountants, money managers, loan processers, wealth advisers, as well as day traders. In the last 25 years, many financial models that utilize z score has been proved to be successful as a predictor of corporate bankruptcy.
Compare to competition

In accordance with the company's disclosures, Chemocentryx has a Z Score of 1.4. This is 79.26% lower than that of the Healthcare sector and 58.08% lower than that of the Biotechnology industry. The z score for all United States stocks is 83.94% higher than that of the company.

Chemocentryx Z Score Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Chemocentryx's direct or indirect competition against its Z Score to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Chemocentryx could also be used in its relative valuation, which is a method of valuing Chemocentryx by comparing valuation metrics of similar companies.
Chemocentryx is currently under evaluation in z score category among related companies.

Chemocentryx Current Valuation Drivers

We derive many important indicators used in calculating different scores of Chemocentryx from analyzing Chemocentryx's financial statements. These drivers represent accounts that assess Chemocentryx's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Chemocentryx's important valuation drivers and their relationship over time.
201620172018201920202021 (projected)
Net Income Per Employee(642.8 K)270.59 K(499.55 K)(676.7 K)(415.07 K)(447.84 K)
Average Assets124.81 M152.54 M190.61 M223.14 M447.82 M483.18 M
Earnings Before Interest Taxes and Depreciation Amortization EBITDA(39.62 M)18.28 M(36.23 M)(51.7 M)(49.95 M)(51.26 M)
Earnings Before Interest Taxes and Depreciation Amortization USD(39.62 M)18.28 M(36.23 M)(51.7 M)(49.95 M)(51.26 M)
Earnings before Tax(39.96 M)17.86 M(37.97 M)(55.49 M)(55.36 M)(56.81 M)
Average Equity55.9 M50.95 M22.66 M69.99 M317.93 M343.03 M
Enterprise Value339.9 M272.2 M541.85 M2.29 B4.29 B4.63 B
Free Cash Flow38.84 M4.16 M15.6 M(70.91 M)(96.55 M)(99.09 M)
Invested Capital105.51 M121.05 M110.52 M131.18 M498.12 M537.44 M
Invested Capital Average85.79 M87.97 M98.42 M135.44 M323.79 M349.35 M
Market Capitalization353.76 M290.16 M551.24 M2.3 B4.29 B4.62 B
Tangible Asset Value155.87 M189.33 M183.31 M209.08 M518.9 M559.86 M
Working Capital110.36 M146.89 M116.99 M115.28 M390.01 M420.8 M

Chemocentryx Institutional Holders

Institutional Holdings refers to the ownership stake in Chemocentryx that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Chemocentryx's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Chemocentryx's value.
Security TypeSharesValue
Assenagon Asset Management SaCommon Shares104.2 K1.4 M
Cutler Group LpPut Options108.9 K960 K
Alliancebernstein LpCommon Shares70.8 K948 K
Strs OhioCommon Shares49.9 K668 K
New York State Common Retirement FundCommon Shares45.1 K604 K
Belvedere Trading LlcCommon Shares34.1 K550 K
Cutler Group LpCommon Shares38.6 K516 K
Chicago Partners Investment Group LlcCommon Shares24.4 K355 K
Cutler Group LpCall Options58.2 K129 K

Chemocentryx Fundamentals

About Chemocentryx Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Chemocentryx's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Chemocentryx using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Chemocentryx based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
ChemoCentryx, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. ChemoCentryx, Inc. was incorporated in 1996 and is headquartered in Mountain View, California. Chemocentryx operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 133 people.

Chemocentryx Investors Sentiment

The influence of Chemocentryx's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Chemocentryx. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock markets does not have a solid backing from leading economists and market statisticians.

Current Sentiment - CCXI

Chemocentryx Investor Sentiment

Most of Macroaxis users are currently bullish on Chemocentryx. What is your opinion about investing in Chemocentryx? Are you bullish or bearish?
Bullish
Bearish
98% Bullish
2% Bearish
Skip

Pair Trading with Chemocentryx

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Chemocentryx position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Chemocentryx will appreciate offsetting losses from the drop in the long position's value.

Chemocentryx Pair Correlation

Equities Pair Trading Analysis

Correlation analysis and pair trading evaluation for Chemocentryx and Edesa Biotech. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run Pair Correlation  
Continue to Chemocentryx Piotroski F Score and Chemocentryx Valuation analysis. Note that the Chemocentryx information on this page should be used as a complementary analysis to other Chemocentryx's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Global Correlations module to find global opportunities by holding instruments from different markets.

Complementary Tools for Chemocentryx Stock analysis

When running Chemocentryx price analysis, check to measure Chemocentryx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chemocentryx is operating at the current time. Most of Chemocentryx's value examination focuses on studying past and present price action to predict the probability of Chemocentryx's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Chemocentryx's price. Additionally, you may evaluate how the addition of Chemocentryx to your portfolios can decrease your overall portfolio volatility.
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Go
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Go
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Go
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Go
Focused Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Go
ETF Directory
Find actively traded Exchange Traded Funds (ETF) from around the world
Go
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Go
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Go
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Go
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Go
Equity Search
Search for activelly traded equities including funds and ETFs from over 30 global markets
Go
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Go
The market value of Chemocentryx is measured differently than its book value, which is the value of Chemocentryx that is recorded on the company's balance sheet. Investors also form their own opinion of Chemocentryx's value that differs from its market value or its book value, called intrinsic value, which is Chemocentryx's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Chemocentryx's market value can be influenced by many factors that don't directly affect Chemocentryx underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Chemocentryx's value and its price as these two are different measures arrived at by different means. Investors typically determine Chemocentryx value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Chemocentryx's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.